NYSE:VAR - Varian Medical Systems Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Get Started
$133.27 +0.36 (+0.27 %)
(As of 04/24/2019 04:00 PM ET)
Previous Close$132.91
Today's Range$132.76 - $134.84
52-Week Range$101.42 - $142.50
Volume964,867 shs
Average Volume678,516 shs
Market Capitalization$12.10 billion
P/E Ratio30.15
Dividend YieldN/A
Beta0.86
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNYSE:VAR
Previous Symbol
CUSIP92220P10
CIK203527
Webwww.varian.com
Phone650-493-4000

Debt

Debt-to-Equity RatioN/A
Current Ratio1.73
Quick Ratio1.37

Price-To-Earnings

Trailing P/E Ratio30.15
Forward P/E Ratio28.18
P/E Growth3.46

Sales & Book Value

Annual Sales$2.92 billion
Price / Sales4.14
Cash Flow$5.3608 per share
Price / Cash Flow24.86
Book Value$17.35 per share
Price / Book7.68

Profitability

EPS (Most Recent Fiscal Year)$4.42
Net Income$149.90 million
Net Margins12.28%
Return on Equity26.18%
Return on Assets12.44%

Miscellaneous

Employees7,174
Outstanding Shares90,778,000
Market Cap$12.10 billion
Next Earnings Date4/24/2019 (Confirmed)
OptionableOptionable

Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) released its earnings results on Wednesday, April, 24th. The medical equipment provider reported $1.05 earnings per share for the quarter, missing the Zacks' consensus estimate of $1.15 by $0.10. The medical equipment provider earned $779.40 million during the quarter, compared to the consensus estimate of $776.28 million. Varian Medical Systems had a return on equity of 26.18% and a net margin of 12.28%. The business's quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.15 EPS. View Varian Medical Systems' Earnings History.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, April 24th 2019. View Earnings Estimates for Varian Medical Systems.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems updated its FY19 earnings guidance on Wednesday, April, 24th. The company provided earnings per share (EPS) guidance of $4.60-4.75 for the period, compared to the Thomson Reuters consensus estimate of $4.74. The company issued revenue guidance of $3.09-3.18 billion, compared to the consensus revenue estimate of $3.12 billion.Varian Medical Systems also updated its FY 2019 guidance to $4.60-4.75 EPS.

What price target have analysts set for VAR?

9 brokers have issued 1 year price objectives for Varian Medical Systems' stock. Their forecasts range from $105.00 to $162.00. On average, they anticipate Varian Medical Systems' stock price to reach $136.50 in the next year. This suggests a possible upside of 2.4% from the stock's current price. View Analyst Price Targets for Varian Medical Systems.

What is the consensus analysts' recommendation for Varian Medical Systems?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Varian Medical Systems.

What are Wall Street analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:
  • 1. According to Zacks Investment Research, "Varian ended the first quarter of fiscal 2019 on a strong note with earnings meeting estimates and revenues beating the same. Varian continues to gain from core Oncology Segment, which saw solid overseas growth in the quarter. Strength in China buoys optimism. In fact, management foresees tremendous opportunities in China for Varian’s radiation therapy products. Meanwhile, the company’s flagship Halcyon system was granted exclusion from Section 301 tariffs. Additionally, new proton therapy products are building momentum for Varian’s Proton Solutions business. The stock has outperformed the industry in a year’s time. On the flip side, Varian’s gross and operating margins contracted in the quarter. The U.S.-China tariffs also impacted the top line, denting income from the Oncology segment. Varian competes with large electronic companies as well as smaller and more specialized radiation therapy equipment manufacturers." (1/26/2019)
  • 2. Barrington Research analysts commented, "We are maintaining our OUTPERFORM investment rating on VAR shares and are increasing our price target to $135 from our previous $132. We arrive at our price target by attaching a 17.5x multiple to our adjusted EBITDA estimate for FY/19. We assume $800 million in net cash 12 months from now." (1/24/2019)
  • 3. BTIG Research analysts commented, "For its fiscal first quarter, Varian again outperformed on two key metrics: revenue and Oncology gross orders. Revenue of $741.0M topped consensus by ~$20M while Oncology gross orders of $716.5M was ~$60M above estimates. We like that Oncology gross order growth of +17% y/y CC was the highest in a decade and that the strength came from all regions. Still, with VAR shares trading near all-time historical highs, investors were likely seeking perfection. VAR may trade up Thursday, but with gross margins and operating margins coming in below consensus models, we think the positive stock reaction may be just a few dollars." (1/24/2019)

Has Varian Medical Systems been receiving favorable news coverage?

News stories about VAR stock have been trending somewhat positive this week, InfoTrie reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Varian Medical Systems earned a daily sentiment score of 1.7 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the company's share price in the near future.

Who are some of Varian Medical Systems' key competitors?

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include Gilead Sciences (GILD), NVIDIA (NVDA), Micron Technology (MU), General Electric (GE), Align Technology (ALGN), Thermo Fisher Scientific (TMO), Edap Tms (EDAP), Intel (INTC), The Coca-Cola (KO) and Pfizer (PFE).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:
  • Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
  • Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
  • Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
  • Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
  • Mr. Patrick Joda, Sr. VP of Global Operations (Age 61)

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by a number of of retail and institutional investors. Top institutional investors include Oakbrook Investments LLC (0.31%), Saratoga Research & Investment Management (0.26%), BTIM Corp. (0.23%), BB&T Corp (0.20%), DNB Asset Management AS (0.11%) and LaFleur & Godfrey LLC (0.11%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, David J Illingworth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

Which major investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including Saratoga Research & Investment Management, Schaper Benz & Wise Investment Counsel Inc. WI, Meeder Asset Management Inc., Arlington Partners LLC, LaFleur & Godfrey LLC, Retirement Systems of Alabama, Speece Thorson Capital Group Inc. and Rockland Trust Co.. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

Which major investors are buying Varian Medical Systems stock?

VAR stock was bought by a variety of institutional investors in the last quarter, including DNB Asset Management AS, BTIM Corp., Field & Main Bank, BB&T Corp, Oakbrook Investments LLC, Nisa Investment Advisors LLC, Stock Yards Bank & Trust Co. and WESPAC Advisors LLC. View Insider Buying and Selling for Varian Medical Systems.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $133.27.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $12.10 billion and generates $2.92 billion in revenue each year. The medical equipment provider earns $149.90 million in net income (profit) each year or $4.42 on an earnings per share basis. Varian Medical Systems employs 7,174 workers across the globe.

What is Varian Medical Systems' official website?

The official website for Varian Medical Systems is http://www.varian.com.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]


MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  445 (Vote Outperform)
Underperform Votes:  400 (Vote Underperform)
Total Votes:  845
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe VAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/24/2019 by MarketBeat.com Staff

Featured Article: How to Invest in an Index Fund
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel